Download PDF
Pharmacopsychiatry 2000; 33(2): 60-65
DOI: 10.1055/s-2000-7970
Original Paper
Georg Thieme Verlag Stuttgart ·New York

Effect of the Hypericum Perforatum Extract on Serotonin Turnover in the Mouse Brain

P. H. Yu
  • Neuropsychiatry Research Unit, Department of Psychiatry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available at
    Permissions and Reprints

St. John's Wort, a traditional herbal medicine obtained from the extract of Hypericum perforatum, has been used in the treatment of mild depression. Its mechanism of action remains to be established. The present study confirmed that Hypericum extract exhibited very weak inhibitory activities towards MAO. Mouse brain MAO activities was unchanged following either acute or chronic treatment with Hypericum extract. 5-HIAA levels were found to be significantly increased in the cerebral cortex, hypothalamus, hippocampus and caudate 3 h after treatment with the Hypericum extract at a dose as low as 10 mg/Kg. An increase of 5-HT levels was also observed in hypothalamus and hippocampus. The increase of brain 5-HIAA was not further enhanced following chronic administration of the herb. The Hypericum extract significantly reduced the plasma tryptophan levels, the precursor of 5-HT. The action of Hypericum extract is consistent with the notion that serotonergic system is involved. The effect of Hypericum extract on the brain 5-HIAA and 5-FIT levels appeared to be quite different from the effect of classical 5-HT re-uptake blockers.

References

  • 1 Bladt S, Wagner H. Inhibition of MAO by fractions and constituents of hypericum extract.  Journal of Geriatric Psychiatry and Neurology. 1994;  7 (Suppl. 1) -59
    PubMedGoogle Scholar
  • 2 Butterweck V, Petereit F, Winterhoff H, Nahrstedt A. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test.  Planta Medicine. 1998;  64 291-294
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Butterweck V, Wall A, Lieflander-Wulf H, Winterhoff H, Nahrstedt A. Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity.  Pharmacopsychiatry. 1997;  30 (Suppl. 2) 117-124
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Caccia S, Anelli M, Codegoni A M, Fracasso C, Garattini S. The effects of single and repeated anorectic doses of 5-hydroxytrptamine uptake inhibitors on indole levels in rat brain.  British Journal of Pharmacology. 1993;  110 355-359
    PubMedGoogle Scholar
  • 5 Carlsson, Lindqvist M. Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino acids in rat brain.  Naunyn Sckmiedebergs Archives of Pharmacology. 1978;  303 -164
    PubMedGoogle Scholar
  • 6 Chatterjee S S, Noldner M, Koch E, Erdelmeier C. Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility.  Pharmacopsychiatry. 1998;  31 (Suppl. 1) 7-15
    PubMedGoogle Scholar
  • 7 Cott J M. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract.  Pharmacopsychiatry. 1997;  30 (Suppl. 2) 108-112
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Dimpfel W, Schober F, Manne M. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).  Pharmacopsychiatry. 1998;  31 (Suppl. 1) -35
    PubMedGoogle Scholar
  • 9 Ernst E. St. John's wort as antidepressive therapy.  Fortschrift Medicine. 1995;  113 354-355
    PubMedGoogle Scholar
  • 10 Fernstrom J D. Role of precursor availability in control of monoamine biosynthesis in brain.  Physiology Review. 1983;  63 484-546
    PubMedGoogle Scholar
  • 11 Friedman P A, Kappelman A H, Kaufman S. Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain.  Journal of Biological Chemistry. 1972;  247 4165-4173
    PubMedGoogle Scholar
  • 12 Fuller R W. Role of serotonin in therapy of depression and related disorders.  Journal of Clinical Psychiatry. 1991;  52 (Suppl. 1) 52-57
    PubMedGoogle Scholar
  • 13 Girzu M, Carnat A, Privat A M, Fialip J, Carnat A P. Sedative activity in mice of an hydroalcoholic extract of hypericum perforatum L.  Phytotherapeutical Research. 1977;  11 3956-397
    PubMedGoogle Scholar
  • 14 Golsch S, Vocks E, Rakoski J, Nrockow K, Ring J. Reversible increase of photosensitivity by St. John's wort extract.  Hautarzt. 1997;  48 -252
    PubMedGoogle Scholar
  • 15 Halama P. Wirksamkeit des Johanrnskrautextraktes LI 160 bei depressiver Verstimmung.  Nervenheilkunde. 1991;  10 250-253
    PubMedGoogle Scholar
  • 16 Kaehler S T, Sinner C, Chatterjee S S, Philippu A. Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus.  Neurosci. Lett.. 1999;  262 -202
    PubMedGoogle Scholar
  • 17 Laakmann G, Schule C, Baghai T, Kieser M. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.  Pharmacopsychiatry. 1998;  31 (Suppl 1) 54-59
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Linde K, Ramirez G, Mulrow C D, Pauls A, Weidenhammer W, Melchart D. St. John's wort for depression: an overview and meta-analysis of randomized clinical trials.  British Medical Journal. 1996;  313 253-258
    PubMedGoogle Scholar
  • 19 Lookingland K J, Shannon N J, Chapin D S, Moore K E. Exogenous tryptophan increases synthesis, storage, and intraneuronal metabolism of 5-hydroxytryptamine in the rat hypothalamus.  Journal of Neurochemistry. 1986;  47 205-212
    PubMedGoogle Scholar
  • 20 Martinez B, Kasper S, Ruhrmann S, Moller H J. Hypericum in the treatment of seasonal affective disorders.  Journal of Geriatric Psychiatry and Neurology. 1994;  7 (Suppl. 1) -33
    PubMedGoogle Scholar
  • 21 Muldner H, Zoller M. Antidepressive effect of a Hypericum extract standardized to an active hypericin complex; Biochemical and clinical studies.  Arzneimittelforschung. 1984;  34 918-920
    PubMedGoogle Scholar
  • 22 Müller W E, Singer A, Wonnemann M, Hafner U, Rolli M, Schafer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.  Pharmacopsychiatry. 1998;  31 (Suppl. 1) 16-21
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Müller W E, Rolli M, Schafer C, Hafner U. Effects of hypericum extract (Li 160) in biochemical models of antidepressant activity.  Pharmacopsychiatry. 1997;  30 (Suppl. 1) 102-107
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Müller W E, Rossol R. Effects of hypericum extract on the expression of serotonin receptors.  Journal of Geriatric Psychiatry and Neurology. 1994;  7 (Suppl. 1) -64
    PubMedGoogle Scholar
  • 25 Okpanyi S N, Weischer M L. Animal experiments on the psychotrophic action of a Hypericum extract.  Arzneimittelforschung. 1987;  37 10-13
    PubMedGoogle Scholar
  • 26 Ozturk Y, Aydin S, Bei R, Baser K HC, Berberoglu H. Effects of Hypericum calycinum L. extract on the central nervous system in mice.  Phytotherpeutic Research. 1996;  10 700-702
    PubMedGoogle Scholar
  • 27 Perovic S, Müller W EG. Pharmacological profile of Hypericum extract; Effect on serotonin uptake by postsynaptic receptor.  Arzneimittel Forschung. 1995;  45 1145-1148
    PubMedGoogle Scholar
  • 28 Reh C, Laux P, Schenk N. Hypericum-Extrakt bei Depressionen eine wirksame Alternative.  Therapiewoche. 1992;  42 1576-1581
    PubMedGoogle Scholar
  • 29 Schellenberg R, Sauer S, Dimpfel W. Pharmacodynamic effects of two different Hypericum extract in healthy volunteers measured by quantitative EEC.  Pharmacopsychiatry. 1998;  31 (Suppl. 1) -53
    PubMedGoogle Scholar
  • 30 Schulz H, Jobert M. Effects of hypericum extract on the sleep EEC in older volunteers.  Journal of Geriatric Psychiatry and Neurology. 1994;  7 (Suppl. 11) -43
    PubMedGoogle Scholar
  • 31 Simmen U, Burkard W, Berger K, Schaffner W, Lundstrom K. Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system.  J. Recept. Signal Transduct. Res.. 1999;  19 59-74
    PubMedGoogle Scholar
  • 32 Teifel-Mayer R, Gleitz J. Effects of long-term administration of Hypericum extract on the affinity and density of the central serotonergic 5-HT1A and 5-HT2A receptors.  Pharmacopsychiaty. 1997;  30 (Suppl. 2) 113-116
    PubMedGoogle Scholar
  • 33 Thiede H M, Walper A. Inhibition of MAO and COMT by Hypericum extract and hypericin.  Journal of Geriatric Psychiatry and Neurology. 1994;  7 (Suppl. 1) -56
    PubMedGoogle Scholar
  • 34 Volz H P. Controlled clinical trials of Hypericum extract in depressed patients - an overview.  Pharmacopsychiatry. 1997;  30 (Suppl. 2) 72-76
    PubMedGoogle Scholar
  • 35 Wheatley D. Hypericum in seasonal affective disorder (SAD).  Curr. Med. Res. Opin.. 1999;  15 33-37
    PubMedGoogle Scholar
  • 36 Wheatley D. Hypericum extract- potential in the treatment of depression.  CNS Drugs. 1988;  9 431-440
    PubMedGoogle Scholar
  • 37 Woelk H, Burkhard G, Grunwald J. Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients.  Journal of Geriatric Psychiatry and Neurology. 1994;  7 (Suppl. 1) 34-38
    PubMedGoogle Scholar
  • 38 Wong A H, Smith M, Boon H S. Herbal remedies in psychiatric practice.  Arch. Gen. Psychiat.. 1998;  55 1033-1044
    CrossrefPubMedGoogle Scholar
  • 39 Young S N. The clinical psychopharmacology of tryptophan.  Nutrition and the Brain. 1986;  7 49-88
    PubMedGoogle Scholar
  • 40 Yu P H. Monoamine Oxidase. In: Boulton AA, Baker GB, Yu PH) (eds.) Neuromethods Volume V: Neurotransmitter Enzymes. Humana Press Clifton, New Jersey; 1986: 235-272
    Google Scholar
  • 41 Yu P H, Davis B A, Durden D A, Barber, Terleckyj I, Nicklas W G, Boulton A S. Neurochemical and neuroprotective effects of some aliphatic propargylamine MAO-B inhibitors.  Journal of Neurochemistry. 1994;  62 697-704
    PubMedGoogle Scholar

Dr. Peter H. Yu

Neuropsychiatry Research Unit Department of Psychiatry University of Saskatchewan

Saskatoon, Saskatchewan

S7N5E4 Canada

Email: YUP@SASK.USASK.CA

      >